Natus Medical Research and Development Expense Trend

Natus Medical Incorporated -- USA Stock  

USD 39.9  0.2  0.5%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Research and Development Expense of Natus Medical Incorporated with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Research and Development Expense  10 Years Trend  
Increasing
Slightly volatile
 Research and Development Expense 
      Timeline 

Natus Medical Research and Development Expense Over Time

2015-12-31  30,434,000 
2016-12-31  33,443,000 
2017-12-31  33,619,474 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  23,948,789
Geometric Mean  21,355,418
Coefficient Of Variation  38.5
Mean Deviation  7,714,491
Median  29,966,000
Standard Deviation  9,220,372
Range  29,337,474
R Value  0.94
R Squared  0.88
Significance  0.00000582
Slope  2,402,245

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
2 days ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 117.4